135 related articles for article (PubMed ID: 8793522)
21. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure.
Bozzini N; Rodrigues CJ; Petti DA; Bevilacqua RG; Gonçalves SP; Pinotti JA
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):330-4. PubMed ID: 12716317
[TBL] [Abstract][Full Text] [Related]
22. The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Van der Spuy ZM; Fieggan AG; Wood MJ; Pienaar CA
Horm Res; 1989; 32 Suppl 1():137-40. PubMed ID: 2533144
[TBL] [Abstract][Full Text] [Related]
23. GnRH agonists: an alternative to surgery?
Maheux R
Hum Reprod; 1996 Nov; 11 Suppl 3():43-50. PubMed ID: 9147101
[No Abstract] [Full Text] [Related]
24. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
McClelland HR; Quinn AJ
Ulster Med J; 1992 Apr; 61(1):51-5. PubMed ID: 1535743
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment with Zoladex improves surgery for uterine fibroids.
Oncology (Williston Park); 1991 Jan; 5(1):94. PubMed ID: 1828691
[No Abstract] [Full Text] [Related]
26. Goserelin administration causing an acute abdomen in a patient with a fibroid uterus.
Basu M; Ahmed AI
J Obstet Gynaecol; 2007 Jan; 27(1):90-1. PubMed ID: 17365475
[No Abstract] [Full Text] [Related]
27. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
West CP; Lumsden MA; Lawson S; Williamson J; Baird DT
Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
[TBL] [Abstract][Full Text] [Related]
28. Relationship between gonadotropin-releasing hormone agonist and myoma cellular activity: preliminary findings on positron emission tomography.
Lee WL; Liu RS; Yuan CC; Chao HT; Wang PH
Fertil Steril; 2001 Mar; 75(3):638-9. PubMed ID: 11239559
[No Abstract] [Full Text] [Related]
29. Experience with a gonadotrophin-releasing hormone agonist prior to myomectomy--comparison of twice- vs thrice-monthly doses and a control group.
Bassaw B; Mohammed N; Jaggat A; Singh-Bhola M; Ramkissoon A; Singh P; Jones K; Maharaj S; Ramsewak S
J Obstet Gynaecol; 2014 Jul; 34(5):415-9. PubMed ID: 24678813
[TBL] [Abstract][Full Text] [Related]
30. Role of goserelin-depot in the clinical management of uterine fibroids.
Cagnacci A; Paoletti AM; Soldani R; Angiolucci M; Arangino S; Falqui A; Melis GB
Clin Exp Obstet Gynecol; 1994; 21(4):263-5. PubMed ID: 7994879
[TBL] [Abstract][Full Text] [Related]
31. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
[TBL] [Abstract][Full Text] [Related]
32. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
[TBL] [Abstract][Full Text] [Related]
33. Goserelin (Zoladex) and the anaemic patient.
Vercellini P; Crosignani PG
Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():33-7. PubMed ID: 8199103
[No Abstract] [Full Text] [Related]
34. Goserelin versus leuprolide before hysterectomy for uterine fibroids.
Lim SS; Sockalingam JK; Tan PC
Int J Gynaecol Obstet; 2008 May; 101(2):178-83. PubMed ID: 18164303
[TBL] [Abstract][Full Text] [Related]
35. [New possibilities for differentiated therapy of leiomyoma of the uterus using the GnRH agonist zoladex].
Gesenhues T; Hackenberg R; Diechert U; Duda V; Sturm G; Schulz KD
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():96-8. PubMed ID: 2522904
[TBL] [Abstract][Full Text] [Related]
36. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
[TBL] [Abstract][Full Text] [Related]
37. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin.
Crow J; Gardner RL; McSweeney G; Shaw RW
Int J Gynecol Pathol; 1995 Jul; 14(3):235-42. PubMed ID: 8600075
[TBL] [Abstract][Full Text] [Related]
38. Genic expression of the uterine leiomyoma in reproductive-aged women after treatment with goserelin.
Borsari R; Bozzini N; Junqueira CR; Soares JM; Hilário SG; Baracat EC
Fertil Steril; 2010 Aug; 94(3):1072-7. PubMed ID: 19481745
[TBL] [Abstract][Full Text] [Related]
39. Symptomatic ascites complicating GnRH analogue use for myoma shrinkage.
Harding SG; Pesce A; McMillan L
Br J Obstet Gynaecol; 1993 Nov; 100(11):1054-6. PubMed ID: 8251456
[No Abstract] [Full Text] [Related]
40. Removal of fibromyomas by laparoscopic surgery after preoperative GnRH analogue--an alternative to abdominal hysterectomy or myomectomy.
Wood C; Maher P
Aust N Z J Obstet Gynaecol; 1996 Nov; 36(4):464-8. PubMed ID: 9006835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
